基因组编辑的应用应如何评估和监管？
How should the applications of genome editing be assessed and regulated?
作者信息
Fears Robin, Ter Meulen Volker
机构信息
Bioscience Programme at European Academies Science Advisory Council, Halle, Germany.
EASAC Working Group on Genome Editing and is at the German National Academy of Sciences Leopoldina, Halle, Germany.
出版信息
Elife. 2017 Apr 4;6:e26295. doi: 10.7554/eLife.26295.
Abstract
An EASAC working group on genome editing recommends that regulators should focus on specific applications of these new techniques rather than attempting to regulate genome editing itself as a new technology.
摘要
欧洲科学院医学科学院基因组编辑工作组建议，监管机构应关注这些新技术的具体应用，而不是试图将基因组编辑本身作为一项新技术进行监管。
相似文献
1
How should the applications of genome editing be assessed and regulated?基因组编辑的应用应如何评估和监管？
Elife. 2017 Apr 4;6:e26295. doi: 10.7554/eLife.26295.
2
CRISPR plants now subject to tough GM laws in European Union.如今，经基因编辑的植物在欧盟受到严格的转基因法规限制。
Nature. 2018 Aug;560(7716):16. doi: 10.1038/d41586-018-05814-6.
3
4
Meeting report of the OECD conference on "Genome Editing: Applications in Agriculture-Implications for Health, Environment and Regulation".经合组织“基因组编辑：在农业中的应用——对健康、环境和监管的影响”会议报告
Transgenic Res. 2019 Aug;28(3-4):419-463. doi: 10.1007/s11248-019-00154-1.
5
Separate product from process: framing the debate that surrounds the potential uptake of new breeding technologies.将产品与过程分离：构建围绕新育种技术潜在应用的辩论框架。
Physiol Plant. 2018 Dec;164(4):372-377. doi: 10.1111/ppl.12680. Epub 2018 Jan 18.
6
Use the patent system to regulate gene editing.利用专利制度来规范基因编辑。
Nature. 2018 Oct;562(7728):486-488. doi: 10.1038/d41586-018-07108-3.
7
CRISPR-Cas in Medicinal Chemistry: Applications and Regulatory Concerns.用于药物化学的CRISPR-Cas：应用与监管问题
Curr Top Med Chem. 2017;17(30):3308-3315. doi: 10.2174/1568026618666171211151142.
8
[The Washington summit: orange light for genome editing?].[华盛顿峰会：基因编辑亮起黄灯？]
Med Sci (Paris). 2016 Feb;32(2):217-20. doi: 10.1051/medsci/20163202017. Epub 2016 Mar 2.
9
Heritable Human Genome Editing: The International Commission Report.可遗传的人类基因组编辑：国际委员会报告
JAMA. 2020 Nov 17;324(19):1941-1942. doi: 10.1001/jama.2020.19059.
10
Legal issues regarding gene editing at the beginning of life: an EU perspective.生命起始阶段基因编辑的法律问题：欧盟视角
Regen Med. 2017 Sep;12(6):669-679. doi: 10.2217/rme-2017-0033. Epub 2017 Oct 4.
引用本文的文献
1
Social acceptance of genetic engineering technology.对基因工程技术的社会接受度。
PLoS One. 2023 Aug 16;18(8):e0290070. doi: 10.1371/journal.pone.0290070. eCollection 2023.
2
Genome editing with the CRISPR-Cas system: an art, ethics and global regulatory perspective.CRISPR-Cas 系统基因组编辑：艺术、伦理和全球监管视角。
Plant Biotechnol J. 2020 Aug;18(8):1651-1669. doi: 10.1111/pbi.13383. Epub 2020 Apr 30.
3
Modern Trends in Plant Genome Editing: An Inclusive Review of the CRISPR/Cas9 Toolbox.现代植物基因组编辑趋势：CRISPR/Cas9 工具盒的综合评述。
Int J Mol Sci. 2019 Aug 19;20(16):4045. doi: 10.3390/ijms20164045.
4
The ethics of genome editing in non-human animals: a systematic review of reasons reported in the academic literature.非人类动物基因组编辑的伦理：学术文献中报告的原因的系统综述。
Philos Trans R Soc Lond B Biol Sci. 2019 May 13;374(1772):20180106. doi: 10.1098/rstb.2018.0106.
5
Genome editing of lactic acid bacteria: opportunities for food, feed, pharma and biotech.乳酸菌基因组编辑：在食品、饲料、制药和生物技术方面的机遇。
FEMS Microbiol Lett. 2019 Jan 1;366(1). doi: 10.1093/femsle/fny291.
6
Transgene-free genome editing in marine algae by bacterial conjugation - comparison with biolistic CRISPR/Cas9 transformation.细菌接合介导的海洋藻类无转基因基因组编辑——与生物弹道 CRISPR/Cas9 转化的比较。
Sci Rep. 2018 Sep 26;8(1):14401. doi: 10.1038/s41598-018-32342-0.
7
Assessing Security Implications of Genome Editing: Emerging Points From an International Workshop.评估基因编辑的安全影响：国际研讨会的新观点
Front Bioeng Biotechnol. 2018 Mar 28;6:34. doi: 10.3389/fbioe.2018.00034. eCollection 2018.
本文引用的文献
1
Safeguarding the future of human gene editing.保护人类基因编辑的未来。
Lancet. 2017 Feb 18;389(10070):671. doi: 10.1016/S0140-6736(17)30389-6. Epub 2017 Feb 17.
2
Cornerstones of CRISPR-Cas in drug discovery and therapy.CRISPR-Cas在药物发现与治疗中的基石。
Nat Rev Drug Discov. 2017 Feb;16(2):89-100. doi: 10.1038/nrd.2016.238. Epub 2016 Dec 23.
3
New CRISPR-Cas systems from uncultivated microbes.来自未培养微生物的新型CRISPR-Cas系统。
Nature. 2017 Feb 9;542(7640):237-241. doi: 10.1038/nature21059. Epub 2016 Dec 22.
4
Patterns of CRISPR/Cas9 activity in plants, animals and microbes.植物、动物和微生物中CRISPR/Cas9的活性模式。
Plant Biotechnol J. 2016 Dec;14(12):2203-2216. doi: 10.1111/pbi.12634. Epub 2016 Oct 11.
5
Governance: Learn from DIY biologists.治理：向DIY生物学家学习。
Nature. 2016 Mar 10;531(7593):167-8. doi: 10.1038/531167a.
6
Can CRISPR-Cas9 gene drives curb malaria?CRISPR-Cas9基因驱动能遏制疟疾吗？
Nat Biotechnol. 2016 Feb;34(2):149-50. doi: 10.1038/nbt.3473.
7
Gene-edited pigs are protected from porcine reproductive and respiratory syndrome virus.基因编辑猪对猪繁殖与呼吸综合征病毒具有抵抗力。
Nat Biotechnol. 2016 Jan;34(1):20-2. doi: 10.1038/nbt.3434. Epub 2015 Dec 7.
8
Biohackers gear up for genome editing.生物黑客们为基因编辑做好准备。
Nature. 2015 Aug 27;524(7566):398-9. doi: 10.1038/524398a.
9
A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity.可编程的双 RNA 引导的 DNA 内切酶在适应性细菌免疫中的作用。
Science. 2012 Aug 17;337(6096):816-21. doi: 10.1126/science.1225829. Epub 2012 Jun 28.
Zotero 插件